重组人表皮生长因子透皮吸收实验研究

姜国辉;唐刚华;苗小春;郑连芳;王世真

中国药学杂志 ›› 1999, Vol. 34 ›› Issue (11) : 746-749.

中国药学杂志 ›› 1999, Vol. 34 ›› Issue (11) : 746-749.
药剂

重组人表皮生长因子透皮吸收实验研究

  • 姜国辉;唐刚华;苗小春;郑连芳;王世真
作者信息 +

Study on the percutaneous absorption of recombination human epidermal growth factor

  • Jiang Guohui
Author information +
文章历史 +

摘要

目的:探讨表皮生长因子(EGF)在皮肤表面的吸收、透过及代谢?方法:采用氯胺-T法制备125I-EGF?采用放射性同位素直接测定法及三氯乙酸(TCA)沉淀法观察EGF不同时间累积透过量和透皮率及各时间段透过量和透皮率?结果:3 个剂量组12h累积透皮率均小于1%,EGF累积透皮率随涂抹剂量增大而减少,涂抹剂量与其透皮率呈非线性关系?结论:EGF透过皮肤时仅有极少量分解代谢,EGF作为局部外用药时透皮吸收量很少,可忽略作为外用药时全身吸收所产生的作用?本研究为今后的临床研究提供必要的参考资料?

Abstract

OBJECTIVE:To study the absorption,permeation and metabolism of epidermal growth factor (EGF) in the surface of the skin.METHODS:125I-EGF was labelled with Chloramine-T method and a Franz diffusion cell syntem was developed for the percutaneous absorption study.The accumulated permeation amount and ratio of 125I-EGF at the different time were determined by the direct radioisotope tracing assay and the trichloroacetic acid (TCA) precipitation method.RESULTS:The total accumulated permeability ratios during 12h were all less than 1% at the different dose of 125I-EGF.There was no linearity between the dose of 125I-EGF smeared on the surface of the skin and the accumulated permeability ratio. CONCLUSION:The study provided necessary imformation for further clinical trial.

关键词

表皮生长因子 / 同位素示踪

Key words

epidermal growth factor / isotope tracing assay / percutaneous absorption

引用本文

导出引用
姜国辉;唐刚华;苗小春;郑连芳;王世真. 重组人表皮生长因子透皮吸收实验研究[J]. 中国药学杂志, 1999, 34(11): 746-749
Jing Guohui . Study on the percutaneous absorption of recombination human epidermal growth factor[J]. Chinese Pharmaceutical Journal, 1999, 34(11): 746-749

参考文献

1 Fisher DA,Lakshmanan J.Metabolism and effects of epidermal growth factor and related growth factors in mammals.Endocrinol Rev,1990,11:418. 2 Amagse H.Possible mechanish of gastric mucosal protection by epidermal growth factor in rats:Life Sci,1990,47:1203. 3 Brown GL,Naney LB,Griftell S,et al.Enhancement of wound healing by topical treatment with growth factor.New Engl J Med,1989,321:76. 4 Calel B,Fagerholm P.Human epidermal growth factor the influence on the healing of surgically closed comedal wounds.Acta Ophthalmol (Suppl 182),1987,65:58. 5 Sumi SI,Hasegawa A,Yagi S,et al.Overproduction of human epidermal growth factor/urogastone in escherichie coli and demobstration of its full biological activity.J Biotechnol,1985,15:51. 6 Graham C,Stanley C.125I-Labeled human epidermal growth factor binding internalization,and degration in human fiboblasts.J Cell Bio,1976,71;159. 7 Graham C,Kenneth J,Martin M,et al.Characterization of the binding of 125I-labeled epidermal growth factorto human fibroblasts J Bio Chem,1975,250(11):4297. 8 Bronaugh RL,Stewart RF.Methods for in vitro percutaneous absorption studies IV:the flow-through diffusion cell.J Pharm Sci, 1985,74(1):64. 9 王锐,国俊华,张远,等.丹皮酚体外透皮吸收研究.中草药,1991,6(22):266. 10 杜建平,陈济民.药物透皮吸收研究的实验方法.药学通报,1988,23(6):323.

Accesses

Citation

Detail

段落导航
相关文章

/